Thomas A. McCourt, Chief Executive Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 122,462 shares at $11.41 ($1.4M) on 2023-02-27, disclosed to the SEC on 2023-03-01.
Seasonal sale ($1.4M) by Chief Executive Officer — this insider has traded IRWD in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.41 | 4,409 | $50K | 3.6% |
| 2 | $11.41 | 4,409 | $50K | 3.6% |
| 3 | $11.41 | 25,595 | $292K | 21.0% |
| 4 | $11.41 | 25,595 | $292K | 21.0% |
| 5 | $11.31 | 4,588 | $52K | 3.7% |
| 6 | $11.31 | 4,588 |
| $52K |
| 3.7% |
| 7 | $11.31 | 26,639 | $301K | 21.7% |
| 8 | $11.31 | 26,639 | $301K | 21.7% |
| Total | $11.36 avg | 122,462 | $1.4M | 100% |
| Filing → |
| IRWD | SELL | 2025-02-12 | $490K | — | Filing → |
| IRWD | SELL | 2024-05-22 | $872K | — | Filing → |
| IRWD | SELL | 2024-02-14 | $5.4M | — | Filing → |